Erman Akkus shared on X:
“GemCis-NabPaclitaxel vs. GemCis in 1L of advanced biliary tract cancers
SWOG S1815
No PFS or OS benefit
PFS benefit in gallbladder cancer subgroup.”
Authors: Rachna T. Shroff, Gentry King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura Goff, Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind M. Javle, Imane El Dika, Benjamin Tan, Puneet Cheema, Anuj Patel, Renuka Iyer, R. Katie Kelley, Jaykumar Thumar, Anthony El-Khoueiry, Katherine A. Guthrie, E. Gabriela Chiorean, Howard Hochster, and Philip A. Philip.
